Status:
COMPLETED
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
Lead Sponsor:
New York City Health and Hospitals Corporation
Conditions:
Asthma
Pediatric ALL
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will rece...
Detailed Description
The primary objective is to determine the effect of prescribing inhaled corticosteroids in addition to short acting beta agonists and oral corticosteroids (if indicated) from the Pediatric Emergency D...
Eligibility Criteria
Inclusion
- Chief complaint consistent with asthma exacerbation
- Previous diagnosis of asthma by a physician OR one major in the Asthma Predictive Index (API) with two prior episodes of wheezing in the past year.
- Major criteria in the API: parent with asthma, patient with eczema, evidence of sensitization to allergens in the air
- Received oral corticosteroids as part of treatment during this visit for acute asthma exacerbation.
- Deemed well enough after interventions to be discharged by the treating physician.
- If \<5 years of age, possession of nebulizer machine at home.
Exclusion
- Received asthma controller medications within four weeks prior to presentation
- Allergy to intervention asthma controller medications.
Key Trial Info
Start Date :
September 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03369847
Start Date
September 10 2017
End Date
June 30 2019
Last Update
July 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kings County Hospital Center
Brooklyn, New York, United States, 11203